Pharmerica Revenue, Profits - PMC Quarterly Income Statement

Add to My Stocks
$29.05 $0 (0%) PMC stock closing price Aug 18, 2017 (Closing)

Financial analysis of Pharmerica involves more than just checking the Pharmerica stock price, by looking at the financial statements of the company in detail. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement for PMC which implies a QoQ revenue growth of $25.2M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Pharmerica assets and Pharmerica free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have increased from $3.5M QoQ and 2017-Q2 revenue is $592M. View details of revenue and profits for Pharmerica for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Pharmerica Net Sales or Revenues
592M566.8M534.4M512.6M519.6M524.5M520.6M498.8M497.5M511.6M
Cost Of Goods Sold (COGS)502.4M478.9M450.7M434.1M437.8M442.5M433.9M420.2M416.3M423M
Pharmerica Gross Profit
89.6M87.89M83.72M78.49M81.79M82M86.71M78.59M81.2M88.6M
Research & Development Expense----------
Selling General & Admin Expense68.1M69.6M63.7M58.2M66.1M65.9M58.7M63.1M65.7M65.2M
Income Before Depreciation Depletion Amortization21.5M18.29M20.02M20.29M15.69M16.1M28M15.49M15.5M23.4M
Depreciation Depletion Amortization9.9M9.1M9M8.3M8.2M8.2M8M7M7M6.6M
Non Operating Income----------
Interest Expense4.1M3.7M0.2M3M3.3M3M1.2M2.1M1.9M1.4M
Pharmerica Pretax Income
7.5M5.5M10.8M9M4.2M4.9M18.8M6.4M6.6M15.4M
Provision for Income Taxes2.8M2M3.1M1.7M1.7M0.8M-1.4M3.4M4.3M5.8M
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations4.7M3.5M7.7M7.3M2.5M4.1M20.2M3M2.3M9.6M
Extraordinary Items & Discontinued Operations----------
Pharmerica Net Income (Profit/Loss)
4.7M3.5M7.7M7.3M2.5M4.1M20.2M3M2.3M9.6M
Average Shares used to compute Diluted EPS31.68M31.2M31.21M31.07M31.03M30.92M31.01M30.9M30.83M30.73M
Average Shares used to compute Basic EPS31.44M30.84M30.77M30.75M30.73M30.53M30.45M30.43M30.39M30.19M
Income Before Nonrecurring Items14.84M13.17M18M13.82M14.47M13.99M12.45M10.72M10.32M13.6M
Income from Nonrecurring Items-10.14M-9.67M-10.3M-6.52M-11.97M-9.89M7.75M-7.72M-8.02M-4M
Pharmerica Earnings Per Share Basic Net
0.150.110.250.240.080.130.660.100.080.32
Pharmerica Earnings Per Share Diluted Net
0.150.110.250.230.080.130.660.100.070.31
EPS Diluted Before Nonrecurring Items0.470.420.580.440.470.450.410.350.330.44
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

1:29
PMC
It is very helpful to read a report on Pharmerica stock analysis. An investor must check the following items in an income statement:
  • Topline: A growing topline, as seen from the Pharmerica revenue chart, as is the case with Pharmerica indicates a growing business. One needs to compare the QoQ or YoY topline growth of PMC stock with its peers like AMED stock and LHCG stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: Most businesses like Pharmerica try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Pharmerica historical stock prices to check how the price has moved with time. .

Pharmerica Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
39.2570
PS ratio (
price sales ratio
)
0.4141
Operating margin
2
Net profit margin
0.8
Dividend yield
0%